Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Early pregnancy blood pressure patterns tied to hypertension risk years later
Researchers show certain blood pressure patterns during the first 20 weeks of pregnancy were more likely to develop into hypertension later in life.
Heart Rhythm Society legislative advocacy group raising funds for electrophysiology
This week, Heart Rhythm Advocates announced its establishment and called on cardiologists and EPs to support its efforts with membership and joining committees to guide efforts.
Key takeaways from ACC.25: Advances in cardiovascular science
Former American College of Cardiology president Hadley Wilson, MD, executive vice chair of Atrium Health Sanger Heart and Vascular Institute, explains his main takeaway messages from the ACC 2025 late-breaking trials.
New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.

A new analysis in the American Journal of Preventive Medicine examined the association between nearby violent crimes and a person's blood pressure.

The new analysis, published in Blood Advances, examined the impact of hydroxyurea treatment among children and young adults.

Expanded FDA labeling for sacubitril/valsartan could make a massive impact on patient care in the next three years.

The new solutions were designed to help users during diagnostic, interventional and endovascular procedures.

The long-term impacts of COVID-19 infection aren’t well known, and the National Institutes of Health (NIH) plans to change that.

The classifier was developed using imaging data from nearly 2,000 patients.

The Food and Drug Administration has taken a non-stance when it comes to recommending COVID-19 booster shots.

Vizient is also working closely with the two companies to boost patient care.